Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

In Brief: Betaseron needle-free injection

  • News

Executive Summary

Betaseron needle-free injection: Berlex parent Schering AG receives a review letter from FDA requiring "additional material clinical studies in order to use non-traditional delivery mechanisms with its Betaseron," jet injection device manufacturer Bioject states. Schering AG cancels its contract with Portland, Ore.-based Bioject. Berlex will begin offering a 24-hour nurse hotline in the first quarter to provide free injection training and follow-up support for Betaseron patients...

Table

View full table

Tags:
Latest Headlines

EU CHMP Opinions And MAA Updates

MHRA Needs ‘Rebuilding’ After Post-Brexit Loss Of Capacity & Industry Investment

EU & South Korea Sign Deal On Exchange Of Confidential Information

Recent And Upcoming FDA Advisory Committee Meetings

See All
UsernamePublicRestriction

Register

PS029680

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By